Literature DB >> 21858772

Molecular mechanisms of lymphangiogenesis in development and cancer.

Imke Albrecht1, Gerhard Christofori.   

Abstract

The lymphatic system, also named the second vascular system, plays a critical role in tissue homeostasis and immunosurveillance. The past two decades of intensive research have led to the identification and detailed understanding of many molecular players and mechanisms regulating the formation of the lymphatic vasculature during embryonic development. Furthermore, clinical and experimental data clearly demonstrate that the formation of new lymphatic vessels by sprouting lymphangiogenesis from pre-existing lymphatic vessels, or by the de novo formation of lymphatic capillaries also occurs in various pathological conditions, such as cancer and organ transplant rejection, while lymphangiogenesis is non-functional in primary edema. In cancer, lymphatic vessels are one major gateway for invasive tumor cells to leave the primary tumor site and to establish distant organ metastasis. Therefore, the specific targeting of the lymphatic vasculature at the tumor site could be a promising approach to prevent metastasis formation.

Entities:  

Mesh:

Year:  2011        PMID: 21858772     DOI: 10.1387/ijdb.103226ia

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  29 in total

Review 1.  The lymphatic vasculature in disease.

Authors:  Kari Alitalo
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 2.  Novel role of immature myeloid cells in formation of new lymphatic vessels associated with inflammation and tumors.

Authors:  Sophia Ran; Andrew Wilber
Journal:  J Leukoc Biol       Date:  2017-04-13       Impact factor: 4.962

3.  Lymphatics-associated genes are downregulated at transcription level in non-small cell lung cancer.

Authors:  Oksana Kowalczuk; Jerzy Laudanski; Wojciech Laudanski; Wieslawa Ewa Niklinska; Miroslaw Kozlowski; Jacek Niklinski
Journal:  Oncol Lett       Date:  2018-03-02       Impact factor: 2.967

Review 4.  The endometrial lymphatic vasculature: function and dysfunction.

Authors:  Jane E Girling; Peter A W Rogers
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

5.  Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.

Authors:  Kang-Jin Park; Sung-Bum Cho; Young-Lan Park; Nuri Kim; Sun-Young Park; Dae-Seong Myung; Wan-Sik Lee; Sun-Seog Kweon; Young-Eun Joo
Journal:  Gastric Cancer       Date:  2016-01-12       Impact factor: 7.370

6.  Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.

Authors:  Jacob E Koskimaki; Esak Lee; William Chen; Corban G Rivera; Elena V Rosca; Niranjan B Pandey; Aleksander S Popel
Journal:  Angiogenesis       Date:  2012-09-29       Impact factor: 9.596

7.  Prostanoid induces premetastatic niche in regional lymph nodes.

Authors:  Fumihiro Ogawa; Hideki Amano; Koji Eshima; Yoshiya Ito; Yoshio Matsui; Kanako Hosono; Hidero Kitasato; Akira Iyoda; Kazuya Iwabuchi; Yuji Kumagai; Yukitoshi Satoh; Shuh Narumiya; Masataka Majima
Journal:  J Clin Invest       Date:  2014-10-01       Impact factor: 14.808

8.  Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis.

Authors:  Natalie O Karpinich; Daniel O Kechele; Scott T Espenschied; Helen H Willcockson; Yuri Fedoriw; Kathleen M Caron
Journal:  FASEB J       Date:  2012-10-25       Impact factor: 5.191

9.  Obesity inhibits lymphangiogenesis in prostate tumors.

Authors:  Ângela Moreira; Sofia S Pereira; Christiane L Machado; Tiago Morais; Madalena Costa; Mariana P Monteiro
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 10.  Hypoxic control of metastasis.

Authors:  Erinn B Rankin; Amato J Giaccia
Journal:  Science       Date:  2016-04-07       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.